Alissa Interpret Description
Alissa Interpret serves as a comprehensive genomic data interpretation tool designed for enhancing clinical decision-making. It boosts your efficiency, reduces turnaround times, and ensures adherence to regulatory standards through its versatile CGH and NGS tertiary analysis platform dedicated to variant interpretation and reporting. When combined with Agilent’s top-tier SureSelect NGS reagents, the user-friendly secondary NGS analysis tool Alissa Reporter, Magnis walkaway automation, and TapeStation QC, Alissa Interpret achieves peak operational effectiveness for an efficient NGS data analysis process. Access to both external and internal curated variant knowledgebases is readily available, while the automated variant interpretation system speeds up CGH and NGS tertiary analysis. This single platform accommodates various genomic elements such as SNVs, InDels, CNVs, LOH, and fusions, and seamlessly integrates with your LIMS to eliminate any genomic data analysis delays. Furthermore, it fosters collaboration among peers, enabling the sharing of insights and ultimately enhancing diagnostic accuracy. By leveraging Alissa Interpret, laboratories can not only streamline their workflows but also elevate their overall diagnostic performance.
Alissa Interpret Alternatives
Planview Software Product Delivery
Planview Software Product Delivery Solution is a comprehensive enterprise platform that provides delivery intelligence by connecting strategy to execution across development toolchains. It integrates seamlessly with tools such as Azure DevOps, GitHub, and Jira to collect and unify real-time data from across teams. This allows organizations to gain full visibility into their delivery processes and make informed decisions. The platform includes features like cross-team dependency management, capacity planning, and agile planning at both team and portfolio levels. It enables users to analyze workflows, identify bottlenecks, and optimize delivery performance.
Advanced analytics, including DORA metrics, provide insights into engineering efficiency and outcomes. AI-powered roadmapping helps align business objectives with execution strategies. The solution also supports connected OKRs to ensure teams stay aligned with organizational goals. Portfolio-level investment planning and scenario modeling allow leaders to evaluate different strategies. Risk signals are surfaced early through configurable thresholds and flow metrics. By replacing manual reporting with real-time dashboards, Planview improves transparency and decision-making. Ultimately, it helps enterprises deliver digital products more efficiently and with measurable impact.
Learn more
InboxAlly
We work with you to make sure your inbox providers don't send spam emails to your email. In just a matter of weeks, our clients have seen their open rates increase by more than DOUBLE! High-engagement recipients open emails and scroll down as they read. This should be done for almost all emails that are opened, as long as the content is not longer than the page. If a recipient takes an email from spam and goes out of their way, it is telling the inbox provider that they made a mistake. Inbox providers will be able to tell if you move an email from the promotions folder into the primary inbox that you don't agree with their sorting criteria. It and other similar emails should go directly to the primary mailbox. It shows that the recipient is interested in your email content. The inbox provider can interpret this as "This email is extremely important, please do not send it to spam."
Learn more
Emedgene
Emedgene optimizes the workflows involved in tertiary analysis for rare disease genomics and various germline research endeavors. It is specifically built to enhance the speed and reliability of interpreting, prioritizing, curating, and generating research reports for user-defined variants. By incorporating explainable AI (XAI) and automation, Emedgene boosts efficiency across diverse analysis workflows, including genomes, exomes, virtual panels, and targeted panels. The platform facilitates the integration of laboratory processes and NGS instruments with IT systems, streamlining and securing the entire workflow. With continuous advancements in science, technology, and demand, Emedgene empowers users to stay current by offering cutting-edge knowledge graph features, curation tools, and expert support throughout their research journey. Furthermore, it allows laboratories to increase their throughput without the need for additional personnel, thanks to XAI and automated processes. Ultimately, Emedgene enables the deployment of high-throughput workflows for whole genome sequencing (WGS), whole exome sequencing (WES), virtual panels, or targeted panels that seamlessly fit into the digital framework of any lab. This comprehensive approach ensures that researchers can focus on their discoveries while relying on robust technological support.
Learn more
VSClinical
VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.
Learn more
Integrations
No Integrations at this time
Company Details
Company:
Agilent Technologies
Year Founded:
1999
Headquarters:
United States
Website:
www.agilent.com/product/next-generation-sequencing/ngs-data-analysis-interpretation/alissa-interpret-4301560
Media
Recommended Products
Earn up to 16% annual interest with Nexo.
Put idle assets to work with competitive interest rates, borrow without selling, and trade with precision. All in one platform.
Geographic restrictions, eligibility, and terms apply.
Product Details
Platforms
Web-Based
Types of Training
Training Docs
Live Training (Online)
Webinars
In Person
Training Videos
Customer Support
Business Hours
Online Support
Alissa Interpret Features and Options
Alissa Interpret User Reviews
Write a Review- Previous
- Next
